Skip to main content
. 2011 Apr 1;7(2):133–138. doi: 10.1007/s13181-011-0149-3

Fig. 2.

Fig. 2

a Good adherence to HAART regimen, b HIV simulation with one medication (atazanavir) in suboptimal concentration, c simulation of HIV status with one medication in minimal concentration, d simulation of HIV with poor adherence, e simulation of HIV state after prolonged good adherence, f simulated HIV state after prolonged poor adherence